AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!
43
ACS
No high risk of bleeding
and no significant overt
bleeding on DAPT
>I y of DAPT
may be
reasonable
(2b)
Discontinuation of aspirin after 1–3 mo
with continued P2Y12 monotherapy
(2a)
Discontinuation
of P2Y12 after
6 mo may be
reasonable
(2b)
High risk
of bleeding
or overt
bleeding on
DAPT
At least 12 mo
of aspirin +
clopidogrel, or
prasugrel, or
ticagrelor
(1)
